Advertisement

Multiple Sclerosis

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA alert
test tubes
FDA alert
FDA Approves Biosimilar Treatment for Patients With Multiple Sclerosis
11/14/2023

Jessica Ganga

Jessica Ganga
The FDA has approved the first biosimilar treatment for patients living with relapsing forms of multiple sclerosis.
11/14/2023
FDA
FDA
FDA Approves New Generic for Adults With MS
12/06/2019
Three applications for the first generic capsules have been granted by the US Food and Drug Administration.
12/06/2019
Multiple Sclerosis
Multiple Sclerosis
FDA: Stopping MS Medication May Exacerbate Symptoms
11/26/2018
The FDA has released a warning about the potential for an increase in disability in patients with multiple sclerosis who stop taking this immunosuppressant.
11/26/2018
Multiple Sclerosis
Multiple Sclerosis
FDA Approves New Dose of Existing MS Drug
02/13/2018
The US Food and Drug Administration has granted approval to a new dose of a drug used to treat relapsing forms of multiple sclerosis.
02/13/2018
Multiple Sclerosis
Multiple Sclerosis
FDA Approves Generic Option for Relapsing Forms of MS
10/04/2017
The FDA has approved a generic option for the treatment of patients with relapsing forms of multiple sclerosis. For details, including dosage and common adverse effects, read more.
10/04/2017
Multiple Sclerosis
Multiple Sclerosis
FDA Approves Ocrevus for the Treatment of Multiple Sclerosis
03/29/2017
The FDA approved Ocrevus for the treatment of relapsing forms of multiple sclerosis and primary progressive multiple sclerosis in adult patients.
03/29/2017
Multiple Sclerosis
Multiple Sclerosis
FDA Roundup: New Options for Presbyopia, MS
04/22/2015
The FDA has approved new options for the treatment of presbyopia and multiple sclerosis, and issued a recall after an outbreak of listeria.
04/22/2015